Corporate Office


Facility Location


Facility Size


Projected Capacity

537,500 KG/ANNUM

Wiley Asterion Queensland Facility Concept Rendering


Asterion will be developing the largest purpose-built renewable-powered medicinal cannabis glasshouse facility in the developed world with an expected capacity in excess of 500,000 kg per annum.

The glasshouse will house 4.3 million square feet (~40 ha) of cultivation space with growing and environment systems designed for optimal consistent high-volume output. Purpose-built with the most advanced agronomy, horticultural science and technology.

The development will be in three stages consisting of Phase 1) 10 ha glasshouse, plus the manufacturing facility; Phase 2) an additional 10 ha glasshouse; plus Phase 3) 20 ha glasshouse.

EU-GMP Manufacturing

Asterion will be a fully integrated medicinal cannabis pharmaceutical company with a range of products for provision to patients in Australia and overseas. We will supply cannabis flower, oil and gelatin capsules in a range of THC and CBD concentrations.

We will also supply concentrated cannabinoids to be incorporated as the active pharmaceutical ingredients (APIs) in a range of delivery systems, such as edibles/pastilles, sold by third-party partners.

All intermediate and finished products will be manufactured within our on-site EU-GMP facility.

November 18, 2020

Asterion Enters into Contractual Agreement with BESIX Watpac

arrowRead More
August 27, 2020

Asterion Receives Sativa Seeds for its Tissue Culture Program

arrowRead More
August 25, 2020

Asterion Warrants Expiring October 1, 2020

arrowRead More

arrowView All News

Stay up to date with our latest news:

What are you searching for?

Stay up to date with our latest news:

Sign up to receive updates
Are you of legal age in your province or territory of residence?